CollPlant Biotechnologies (CLGN) EBITDA Margin (2018 - 2026)
CollPlant Biotechnologies' EBITDA Margin came in at 8388.89% for the quarter ended Jun 30, 2026, up 6485.54 percentage points from 1903.35% a year earlier.
Powered by 
Analysis
CollPlant Biotechnologies (CLGN) EBITDA Margin (2018 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, CollPlant Biotechnologies reported EBITDA Margin of 1965.09%, up 1962.80 percentage points year-over-year; for the year ended Dec 31, 2025, it was -445.85%, up 2702.31 percentage points from the prior year.
- EBITDA Margin carries a five-year change of -365.37 percentage points (years ended Dec 2020 to Dec 2025).
- Going back by year, EBITDA Margin was -3148.16% in the year ended Dec 31, 2024 (-3089.66 pp), -58.49% in the year ended Dec 31, 2023 (+5299.70 pp), -5358.19% in the year ended Dec 31, 2022 (-5363.55 pp) and 5.36% in the year ended Dec 31, 2021 (+85.84 pp).
- The figure for the quarter ended Jun 30, 2026 represents the highest quarterly EBITDA Margin in data going back to the quarter ended Mar 31, 2018.
- Year-over-year, EBITDA Margin increased in three of the last six quarters, with an average year-over-year change of +1504.90 percentage points.
- The fastest year-over-year change in EBITDA Margin over five years came in the quarter ended Sep 30, 2025 (a gain of 102910.06 percentage points), and the weakest in the quarter ended Sep 30, 2024 (a drop of 97105.23 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,209.53 Bn | 1,178.12 Bn | 19.71 Bn | 53.49% |
| 2 | Johnson & Johnson | 625.18 Bn | 543.70 Bn | 17.26 Bn | 35.95% |
| 3 | AbbVie | 510.63 Bn | 483.79 Bn | 12.70 Bn | 49.01% |
| 4 | Merck | 365.88 Bn | 320.31 Bn | 12.21 Bn | 6.02% |
| 5 | Novartis Ag | 293.11 Bn | 257.51 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.69 Bn | 235.45 Bn | 12.86 Bn | 33.11% |
| 7 | Amgen | 237.29 Bn | 192.69 Bn | 7.24 Bn | 46.01% |
| 8 | Gilead Sciences | 194.23 Bn | 168.34 Bn | 6.22 Bn | -124.26% |
| 9 | Pfizer | 171.73 Bn | 118.68 Bn | 10.94 Bn | 39.16% |
| 10 | CollPlant Biotechnologies | 4.97 Mn | -17.39 Mn | -456,000.00 | -2,255.56% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2,255.56% |
| Dec 31, 2025 | -4,890.00% |
| Sep 30, 2025 | -4,264.94% |
| Jun 30, 2025 | -1,647.49% |
| Mar 31, 2025 | -68.32% |
| Dec 31, 2024 | -2,275.61% |
| Sep 30, 2024 | -107,175.00% |
| Jun 30, 2024 | -1,664.66% |
| Mar 31, 2024 | 4,703.06% |
| Dec 31, 2023 | -1,600.00% |
| Sep 30, 2023 | -10,069.77% |
| Jun 30, 2023 | 58.36% |
| Mar 31, 2023 | 877.37% |
| Dec 31, 2022 | -7,555.17% |
| Sep 30, 2022 | -3,841.28% |
| Jun 30, 2022 | -5,945.45% |
| Dec 31, 2021 | -1,154.84% |
| Sep 30, 2021 | -2,069.29% |
| Jun 30, 2021 | -417.37% |
| Mar 31, 2021 | 70.34% |
API Access
CollPlant Biotechnologies EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=CLGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "CLGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=CLGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();